Intriguingly, CALR is frequently mutated in various human cancers such as myeloproliferative neoplasms (MPNs) [44,45,46], and a recent study shows that COVID-19 patients with MPNs are significantly at higher risk of arterial thrombosis and death compared to non-MPN patients [47]. This evidence concerns the gene CALR and COVID-19.